Tacrolimus treatment in women with repeated implantation failures
Abstract Background Tacrolimus is an immunosuppressive drug that works as a calcineurin inhibitor to improve the reproductive outcomes for women who have experienced multiple implantation failures (RIF) and show elevated type 1 helper T (Th1)/Th2 cell ratios. Methods In the first part of this review...
Saved in:
| Main Authors: | Koji Nakagawa, Rikikazu Sugiyama |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | Reproductive Medicine and Biology |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/rmb2.12558 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Tacrolimus (FK506) promotes placentation and maternal-fetal tolerance through modulating FASN-CEACAM1 pathway
by: Xinhang Meng, et al.
Published: (2025-02-01) -
OBSTETRIC HEMORRHAGES AS A CAUSE OF MATERNAL DEATH IN THE TULA REGION
by: V. G. Volkov, et al.
Published: (2017-06-01) -
A review of the optimization of thyroid function, thrombophilia, immunity and uterine milieu: OPTIMUM treatment strategy for recurrent implantation failure and recurrent pregnancy loss
by: Keiji Kuroda
Published: (2024-01-01) -
Effect of Autologous Platelet-Rich Plasma Therapy on the Pregnancy Outcomes of Women with Repeated Implantation Failure: A Systematic Review and Meta-Analysis
by: Tingting Ma, et al.
Published: (2024-02-01) -
Analysis of maternal fetal outcomes and complete blood count parameters according to the stages of placental abruption: a retrospective study
by: Sevki Sener, et al.
Published: (2025-06-01)